Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion

Pierre Fenaux1, David Bowen, Norbert Gattermann

  • 1Hôpital Avicenne, Assistance Publique, Hôpitaux de Paris and Paris 13 University, Bobigny, France. pierre.fenaux@avc.aphp.fr

Leukemia Research
|July 9, 2010
PubMed